Valley fever (coccidioidomycosis). Centers for Disease Control and Prevention. https://www.cdc.gov/valley-fever/hcp/clinical-overview/index.html. Accessed March 5, 2025.

AskMayoExpert. Coccidioidomycosis. Mayo Clinic; 2023.

Bennett JE, et al. Coccidioidomycosis (Coccidioidies species). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed March 6, 2025.

Bays DJ, et al. Coccidioidomycosis. Infectious Disease Clinics of North America. 2021; doi:10.1016/j.idc.2021.03.010.

Blair JE, et al. Pulmonary primary coccidioidal infection. https://www.uptodate.com/contents/search. Accessed March 13, 2025.

Reducing risk for valley fever. Centers for Disease Control and Prevention. https://www.cdc.gov/valley-fever/prevention/index.html. Accessed March 13, 2025.

Blair JE (expert opinion). Mayo Clinic. Accessed March 24, 2025.

Valley fever (coccidioidomycosis). Centers for Disease Control and Prevention. https://www.cdc.gov/valley-fever/php/statistics/?CDC_AAref_Val=https://www.cdc.gov/fungal/diseases/coccidioidomycosis/statistics.html. Accessed March 24, 2025.

Huff D, et al. Coccidioidomycosis and COVID-19 infection. An analysis from a single medical center within the coccidioidal endemic area. Mycopathologia. 2022; doi:10.1007/s11046-022-00629-6.

Jugler C, et al. Humanization and expression of IgG and IgM antibodies in plants as potential diagnostic reagents for valley fever. Frontiers in Plant Science. 2022; doi:10.3389/fpls.2022.925008.

Coccidioidomycosis clinical trials at Mayo Clinic. Mayo Clinic; 2023. https://www.mayo.edu/research/clinical-trials/search-results?keyword=coccidioidomycosis&studySiteStatusesGrouped=Open/Status%20Unknown. Accessed March 24, 2025.

O'Shaughnessy E, et al. FDA public workshop summary — Coccidioidomycosis (valley fever): Considerations for development of antifungal drugs. Clinical Infectious Diseases. 2022; doi:10.1093/cid/ciab904.

Harris, KM. Allscripts EPSi. Mayo Clinic. April 24, 2025.